New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis

Journal of Dermatology

Volumn 37, Issue 2, 2010, Pages 113-124

  Kawakami, Tamihiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti phosphatidylserine prothrombin complex antibodies; Antineutrophil cytoplasmic autoantibody; Cutaneous polyarteritis nodosa; Henoch Sch nlein purpura; KAWAKAMI algorithm; Livedo racemosa; Palpable purpura

Indexed keywords

ANTI PHOSPHATIDYLSERINE ANTIBODY; ARGATROBAN; CLOPIDOGREL; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOGLOBULIN A; LIPOPROSTAGLANDIN E1; LUPUS ANTICOAGULANT; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG; WARFARIN;

ALGORITHM; ANAPHYLACTOID PURPURA; ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; CHURG STRAUSS SYNDROME; DRUG BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY DISEASE; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROSCOPIC POLYANGIITIS; NECROTIZING ARTERITIS; NEPHROTIC SYNDROME; POLYARTERITIS NODOSA; PRIMARY CUTANEOUS VACULITIS; REVIEW; SKIN BIOPSY; VASCULITIS; WEGENER GRANULOMATOSIS;

ADRENAL CORTEX HORMONES; ALGORITHMS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CRYOGLOBULINEMIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN A; MYELOBLASTIN; PEROXIDASE; POLYARTERITIS NODOSA; PURPURA, SCHOENLEIN-HENOCH; RIBONUCLEOSIDES; TICLOPIDINE; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; WARFARIN;

EID: 76249103930     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00761.x     Document Type: Review

References (56)

1. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990 33 : 1074 1087.
2. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990 33 : 1065 1067.
3. Fries JF, Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990 33 : 1135 1136.
4. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994 37 : 187 192.
5. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007 66 : 222 227.
6. Calabrese LH, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990 33 : 1108 1113.
7. Sørensen SF, Slot O, Tvede N, Petersen J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 2000 59 : 478 482.
8. Grzeszkiewicz TM, Fiorentino DF. Update on cutaneous vasculitis. Semin Cutan Med Surg 2006 25 : 221 225.
9. Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 2007 29 : 32 43.
10. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of anti- phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Arthritis Rheum 2007 57 : 1507 1513.
11. Nakamura T, Kanazawa N, Ikeda T et al. Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria. Arch Dermatol Res 2009 301 : 117 121.
12. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small-vessel vasculitis. J Am Acad Dermatol 1998 39 : 667 690.
13. Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol 2003 48 : 311 340.
14. Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol 2006 45 : 3 13.
15. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum 2008 59 : 561 567.
16. 1 on livedoid vasculitis associated with essential cryoglobulinaemia. Br J Dermatol 2007 157 : 1051 1053.
17. Gibbs MB, English JC 3rd., Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol 2005 52 : 1009 1019.
18. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990 40 : 464 467.
19. Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore) 1999 78 : 209 219.
20. Kraemer M, Linden D, Berlit P. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol 2005 252 : 1155 1166.
21. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 : 295 306.
22. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa. Rheumatology (Oxford) 2009 48 : 508 512.
23. Zelger B, Sepp N, Stockhammer G et al. Sneddon's syndrome. A long-term follow-up of 21 patients. Arch Dermatol 1993 129 : 437 447. (Pubitemid 23118239)
24. Kawakami T, Soma Y, Kawasaki K, Kawase A, Mizoguchi M. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol 2005 141 : 873 878.
25. Kawakami T, Kawanabe T, Saito C et al. Clinical and histopathologic features of 8 patients with microscopic polyangiitis including two with a slowly progressive clinical course. J Am Acad Dermatol 2007 57 : 840 848.
26. Kawakami T, Obara W, Soma Y, Mizoguchi M. Palisading neutrophilic granulomatous dermatitis in a Japanese patient with Wegener's granulomatosis. J Dermatol 2005 32 : 487 492.
27. Nakabayashi K. Slowly progressive, not rapidly progressive, MPO-ANCA positive glomerulonephritis and its characteristics. Intern Med 2002 41 : 418 419.
28. Aoyama T, Shimizu T, Matsuo T et al. MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents. Intern Med 2002 41 : 458 462.
29. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinemia vasculitis. Curr Opin Rheumatol 2002 14 : 29 35.
30. Ferri C, Zignego AL, Giuggioli D et al. HCV and cryoglobulinemic vasculitis. Cleve Clin J Med 2002 69 : SII20 SII23.
31. Kawakami T, Ooka S, Mizoguchi M, Soma Y, Yamazaki M. Remission of Hepatitis B Virus-Related Cryoglobulinemic Vasculitis with Entecavir. Ann Intern Med 2008 149 : 911.
32. Kawakami T, Soma Y, Hosaka E, Mizoguchi M. Churg-Strauss syndrome with cutaneous and neurological manifestations preceding asthma. Acta Derm Venereol 2006 86 : 67 68.
33. Kawakami T, Soma Y, Saito C et al. Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 2006 86 : 144 147.
34. Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol 2006 155 : 983 987.
35. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995 74 : 1185 1190.
36. Csernok E. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003 2 : 158 164.
37. Csernok E, Müller A, Gross WL. Immunopathology of ANCA-associated vasculitis. Int Med 1999 38 : 759 765.
38. Gilligan HM, Bredy B, Brady HR et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996 184 : 2231 2241. (Pubitemid 27023723)
39. Pierangeli SS, Harris EN. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003 12 : 539 545.
40. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004 114 : 321 327.
41. Tizard EJ. Henoch-Schönlein purpura. Arch Dis Child 1999 80 : 380 383.
42. Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL. Increased transforming growth factor-β (TGF-β)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol 2000 122 : 285 290.
43. Erkan D, Lockshin MD. How much warfarin is enough in APS related thrombosis? Thromb Res 2004 114 : 435 442.
44. Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007 115 : 2196 2207.
45. Heitzer T, Rudolph V, Schwedhelm E et al. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 2006 26 : 1648 1652.
46. Kawakami T, Soma Y. Therapeutic effect of clopidogrel on cutaneous polyarteritis nodosa. Arch Dermatol 2010 146 : 100 101.
47. Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 2003 60 : 390 394. (Pubitemid 38196187)
48. Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996 36 : 1081 1092.
49. Yoshioka K, Ohashi Y, Sakai T et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 2000 58 : 317 324.
50. Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H. Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 2000 274 : 87 92.
51. Yeh RW, Jang IK. Argatroban: update. Am Heart J 2006 151 : 1131 1138.
52. 1 on sudden hearing loss. Am J Otolaryngol 2005 26 : 245 248.
53. 1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells. Acta Anaesthesiol Scand 2002 46 : 987 993.
54. 1-induced deconsolidation of a platelet plug. Platelets 2003 14 : 463 471.
55. Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics 2007 120 : 1079 1087.
56. Kaneko K, Nagaoka R, Ohtomo Y, Yamashiro Y. Mizoribine for childhood IgA nephropathy. Nephron 1999 83 : 376 377.